Boston Scientific accounts are for healthcare professionals only.
150,000+ patients treated with the VersaCross Connect RF Transseptal Platform*
The VersaCross Connect RF Transseptal Platform enables an integrated transseptal access workflow, leveraging zero exchange technology to enhance procedural efficiency. Designed for your FARAPULSE™ Pulsed Field Ablation (PFA) Platform and WATCHMAN™ Left Atrial Appendage Closure (LAAC) procedures, our reliable solutions seamlessly integrate into your workflows to help you achieve optimal patient outcomes.
- Overview
- Procedural workflow
- Clinical data
- Resources
- Ordering information
Why choose VersaCross Connect transseptal access solutions?
The VersaCross Connect RF Transseptal Platform
Engineered for improved efficiency in your FARAPULSE PFA and WATCHMAN LAAC procedures

Streamlined transseptal access workflow using VersaCross Connect Access Solution for FARADRIVE compared to the VersaCross Access Solution fixed workflow for FARAPULSE PFA Platform procedures.

Streamlined transseptal access workflow using VersaCross Connect LAAC Access Solution compared to the VersaCross Access Solution fixed workflow for WATCHMAN LAAC procedures.
Publication highlights
VersaCross Connect Access Solution for FARADRIVE
March 2025, Osorio et al., published in Journal of Cardiovascular Electrophysiology
VersaCross Connect Access Solution for FARADRIVE facilitated 100% transseptal crossing success in FARAPULSE Pulsed Field Ablation System procedures.
VersaCross Connect LAAC Access Solution
November 2022, Perrin et al., published in Catheterization and Cardiovascular Interventions
First in-human experience using the VersaCross Connect LAAC Access Solution for WATCHMAN FLX™ Left Atrial Appendage Closure Device implantation was successful in all patients with no procedural complications. VersaCross Connect improved procedural efficiency and saved six steps compared to the standard needle-based workflow.
Clinical experience
Hear from experts on their clinical experiences with the VersaCross Connect RF Transseptal Platform.
VersaCross Connect Access Solution for FARADRIVE
Suneet Mittal, MD shares his experience and workflow tailoring transseptal for FARAPULSE Pulsed Field Ablation Platform procedures with the VersaCross Connect Access Solution for FARADRIVE.
VersaCross Connect LAAC Access Solution
Devi Nair, MD, presents clinical data discussing her experience with the VersaCross Connect LAAC Access Solution for improved procedural efficiency and consistent deployment of WATCHMAN therapy devices, compared to needle-based workflows.
Reda Ibrahim, MD, highlights zero exchange transseptal technology for challenging LAAC cases, reflecting on the clinical advantages of VersaCross Connect LAAC Access Solution integration with WATCHMAN TruSteer™ Access Systems.
Ordering Information
VersaCross Connect Access Solution for FARADRIVE
1. Choose your VersaCross RF Wire |

VersaCross RF Wire |
RF wire length: 180 cm |
Wire diameter: 0.035 in |
Curve diameter: 9 mm (j-tip), 24 mm (pigtail) |
2. Connect with VersaCross Connect Transseptal Dilator |

VersaCross Connect Transseptal Dilator with TRUform shapeable technology |
Inner diameter: 0.035 in |
Outer diameter: 13F |
Usable length: 93 cm |
VersaCross Connect LAAC Access Solution
1. Choose your VersaCross RF Wire |

VersaCross RF Wire |
RF wire length: 180 cm, 230 cm |
Wire diameter: 0.035 in |
Curve diameter: 9 mm (j-tip), 24 mm (pigtail) |
2. Choose your VersaCross Connect Transseptal Dilator to complete your solution |

VersaCross Connect Transseptal Dilator with TRUform shapeable technology |
Inner diameter: 0.035 in |
Outer diameter: 12F |
Usable length: 85 cm |
* 150,000+ patients treated with the VersaCross Connect RF Transseptal Platform inclusive of VersaCross Connect Access Solution for FARADRIVE and VersaCross Connect LAAC Access Solution, US lifetime sales.
† The VersaCross Connect Transseptal Dilator is for use with a 13F (4.4 mm) ID FARADRIVE™ Steerable Sheath which is 74 cm in length, specifically, model: M004PF21M402 (US).
‡ The VersaCross Connect Transseptal Dilator is for use with a 12F (4.2 mm) ID WATCHMAN Access Sheath that is 75 cm in length or the WATCHMAN TruSteer™ Access Sheath that is 67 cm in length, specifically: WATCHMAN Access System [Models: M635TU40060, M635TU10060, M635TU20060]; WATCHMAN TruSeal™ Access System [Models: M635TU70010, M635TU70040, M635TU70020]; WATCHMAN FXD Curve™ Access System [Models: M635TU80010, M635TU80020]; WATCHMAN TruSteer Access System [Model: M635TU90050].
§ Bench testing or pre-clinical study results may not necessarily be indicative of clinical performance. The testing was performed by or on behalf of Boston Scientific. Data on file.
References:
- Sayah N, Simon F, Garceau P, et al. Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair. Catheter Cardiovasc Interv. 2021;97(6):1230-1234. doi:10.1002/ccd.29365
- Dewland TA, Gerstenfeld EP, Moss JD, et al. Randomized Comparison of a Radiofrequency Wire Versus a Radiofrequency Needle System for Transseptal Puncture. JACC Clin Electrophysiol. 2023;9(5):611-619. doi:10.1016/j.jacep.2022.10.017
- Inohara T, Gilhofer T, Luong C, Tsang M, Saw J. VersaCross radiofrequency system reduces time to left atrial access versus conventional mechanical needle. J Interv Card Electrophysiol. 2022;63(1):9-12. doi:10.1007/s10840-020-00931-7
- Deneke T, Nentwich K, Schmitt R, et al. Exchanging Catheters Over a Single Transseptal Sheath During Left Atrial Ablation is Associated with a Higher Risk for Silent Cerebral Events. Indian Pacing Electrophysiol J. 2014;14(5):240-249. Published 2014 Oct 6. doi:10.1016/s0972-6292(16)30795-1
- Harada M, Motoike Y, Nomura Y, et al. Factors associated with silent cerebral events during atrial fibrillation ablation in patients on uninterrupted oral anticoagulation. J Cardiovasc Electrophysiol. 2020;31(11):2889-2897. doi:10.1111/jce.14716